Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Long-term Survival following Surgical Resection for Recurrence of Pulmonary Pleomorphic Carcinoma

폐에 발생한 다형태 암종 환자에서 전이부위 절제술 후 장기 생존

  • Lee, Jin-Gu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Park, In-Kyu (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Kim, Dae-Joon (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Byeon, Cheon-Sung (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine) ;
  • Cho, Sang-Ho (Department of Pathology, Yonsei University College of Medicine) ;
  • Chung, Kyung-Young (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
  • 이진구 (연세대학교 의과대학 흉부외과학교실) ;
  • 박인규 (연세대학교 의과대학 흉부외과학교실) ;
  • 김대준 (연세대학교 의과대학 흉부외과학교실) ;
  • 변천성 (연세대학교 의과대학 흉부외과학교실) ;
  • 조상호 (연세대학교 의과대학 병리학교실) ;
  • 정경영 (연세대학교 의과대학 흉부외과학교실)
  • Published : 2007.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Pulmonary pleomorphic carcinomas are rare malignant tumors that account for 0.1 to 0.4% of all lung cancers. They are notable for their aggressive clinical behavior and poor prognosis. We report here on a patient who is alive and disease-free 12 years after receiving surgical treatment for the rib recurrence of pulmonary pleomorphic carcinoma.

폐에서 다형태 암종은 전체 폐암의 $0.1{\sim}0.4%$를 차지하는 매우 드문 악성 종양으로 나쁜 임상경과와 좋지 않은 예후로 알려져 있다. 저자들은 폐에 발생한 다형태 암종 치료 후 발생한 늑골전이에서 외과적 치료를 통해 12년의 무병 장기 생존을 얻었기에 보고하는 바이다.

Keywords

References

  1. Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomophic (spindle) cell carcinoma; Peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer 2001;34:91-7
  2. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Orgnization classification of lung tumors. Semin Roentgenol 2005;40:90-7 https://doi.org/10.1053/j.ro.2005.01.001
  3. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-68 https://doi.org/10.1183/09031936.01.00275301
  4. World Health Organization. Histological typing of lung tumors. Geneva: WHO. 1981
  5. Raveglia F, Mezzetti M, Panigalli T, et al. Personal experience in surgical management of pulmonary pleomorphic carcinoma. Ann Thorac Surg 2004;78:1742-7 https://doi.org/10.1016/j.athoracsur.2004.04.084
  6. Rossi G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 2003;27:311-24 https://doi.org/10.1097/00000478-200301000-00004
  7. Koss MN, Hochholzer L, Frommelt AR. Carcinosarcomas of the lung: a clinicopathologic study of 66 patiests. Am J Surg Pathol 1999;23:1514-26 https://doi.org/10.1097/00000478-199912000-00009
  8. Pfister DG, Johnson DH, Azzoli CG, et al. American society of clinical oncology treatment of unresectable nonsmall cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-53 https://doi.org/10.1200/JCO.2004.09.053